GHRP-6 10 mg
Also known as · Growth Hormone Releasing Peptide 6
GHRP-6 is one of the first-generation growth-hormone-releasing peptides. Broader activity than ipamorelin — also elicits hunger response via ghrelin-receptor central effects.
Chemistry quick-facts
- CAS
- 87616-84-0
- Formula
- C46H56N12O6
- MW
- 872.99 Da
- Length
- 6 aa
- Status
- Preclinical / early clinical research peptide. No approved indication.
- Purity (HPLC)
- ≥ 99.0%
Mechanism of action
Non-selective ghrelin-receptor (GHSR-1a) agonism — pulsatile GH release plus orexigenic signalling.
Research context
GHRP-6 was one of the original GH-releasing hexapeptides, developed in the 1980s. As a non-selective ghrelin-receptor agonist, it elicits broader physiological effects than the later selective agonist ipamorelin, including measurable increases in appetite signalling.
Published studies
A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.
- Bowers CY, Momany FA, Reynolds GA, Hong A (1984). On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology.
Reconstitution
- Solvent
- Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
- Typical volume
- 1 – 2 mL
- · Inject diluent slowly down the side of the vial onto the cake.
- · Swirl gently — do not shake.
- · Solution should be clear and colourless. Discard if not.
Storage
- Lyophilised
- −20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
- Reconstituted
- 2–8 °C, original vial, consumed within 4 weeks.
- Shelf life — sealed
- 24 months from date of manufacture when stored lyophilised at −20 °C.
FAQ
Why choose GHRP-6 over ipamorelin?+
Different research profiles. Ipamorelin is cleaner (no cortisol/prolactin effects). GHRP-6 is broader and elicits orexigenic effects that may be desired or undesired in a research protocol.
This page summarises the research literature on GHRP-6 10 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.
- ResearchIpamorelin 10 mg
Ipamorelin is a selective ghrelin-receptor (GHSR) agonist. One of the cleanest pharmacological profiles in the growth-hormone-secretagogue class.
- ResearchCJC-1295 with DAC 5 mg
CJC-1295 with Drug Affinity Complex (DAC) — an extended GHRH analogue designed for half-life extension through covalent albumin binding.
- ResearchCJC-1295 no DAC 10 mg
CJC-1295 without DAC — short-acting modified GRF(1-29). Commonly used in preclinical GH-pulse research alongside ipamorelin.
- GlossaryGHRH
Growth hormone-releasing hormone, the hypothalamic peptide that triggers GH release.
- GlossaryIGF-1
Insulin-like growth factor 1 — the main downstream mediator of growth hormone effects.
- GlossaryGHS receptor (GHSR-1a)
The growth-hormone secretagogue receptor — also called the ghrelin receptor.